Cravath Team Named “Litigators of the Week” by The Am Law Litigation Daily for Successful Defense of Amgen Against FTC’s Challenge to Acquisition of Horizon Therapeutics

On September 8, 2023, The Am Law Litigation Daily featured a Cravath team, led by partner Timothy G. Cameron and of counsel Jesse M. Weiss, as “Litigators of the Week” for its successful defense of Amgen, one of the world’s largest biopharmaceutical companies, against a Federal Trade Commission (“FTC”) challenge to Amgen’s pending $27.8 billion acquisition of Horizon Therapeutics (“Horizon”)—securing a consent order on September 1, 2023 that ends all litigation and clears the path for the transaction to close.

In the Q&A, the contributions of numerous other Cravath lawyers were mentioned including partners Keith R. Hummel, Rachel G. Skaistis, Margaret T. Segall and Sharonmoyee Goswami, practice area attorneys Benjamin J. Bauer and Omar Debs and associates Hussein Elbashir Elbakri, Catherine G. Sheets, Megan Eloise Vincent, Frances C. McDonald, Kelsey A. Miller, Chizoba D. Ukairo, Kendra M. Kumor and Kristina Stankovic-Kania.

For more detail on the Firm’s representation, please click here to read the related website item.